| Class 435 | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY |
| Click here for a printable version of this file | |
Expand/Contract Processing Please Wait
![[List of Pre Grant Publications for class 435 subclass 1.1]](../as.gif) | ![[List of Patents for class 435 subclass 1.1]](../ps.gif) | 1.1 | DIFFERENTIATED TISSUE OR ORGAN OTHER THAN BLOOD, PER SE, OR DIFFERENTIATED TISSUE OR ORGAN MAINTAINING; COMPOSITION THEREFOR |
| | 2 | MAINTAINING BLOOD OR SPERM IN A PHYSIOLOGICALLY ACTIVE STATE OR COMPOSITIONS THEREOF OR THEREFOR OR METHODS OF IN VITRO BLOOD CELL SEPARATION OR TREATMENT |
| | 3 | CONDITION RESPONSIVE CONTROL PROCESS |
| | 4 | MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP |
| | 5 |  Involving virus or bacteriophage |
| | 6.1 | Involving nucleic acid |
| | 6.12 |  With significant amplification step (e.g., polymerase chain reaction (PCR), etc.) |
| | 6.13 | Drug or compound screening involving gene expression |
| | 6.14 | Detecting cancer |
| | 6.15 | Involving bacterium, fungus, parasite or protozoan (e.g., detecting pathogen virulence factors, adhesions, toxins, etc.) |
| | 6.16 | Involving a nucleic acid encoding a protein related to the nervous system, (e.g., nerve related factors, brain-derived cytokines, nerve cell biomarker, etc.) |
| | 6.17 | Involving a nucleic acid encoding a receptor, cytokine, hormone, growth factor, ion channel protein, or membrane transporter protein |
| | 6.18 | Involving a nucleic acid encoding an enzyme |
| | 6.19 | Detecting nucleic acid by specific antibody, protein or ligand-receptor binding assay |
| | 7.1 | Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay |
| | 7.2 | Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate |
| | 7.21 |  Animal cell |
| | 7.22 |  Parasite or protozoa |
| | 7.23 | Tumor cell or cancer cell |
| | 7.24 | Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.) |
| | 7.25 | Erythrocyte |
| | 7.3 | Flagellar-antigen or pili-antigen |
| | 7.31 | Fungi (e.g., yeast, mold, etc.) |
| | 7.32 | Bacteria or actinomycetales |
| | 7.4 | To identify an enzyme or isoenzyme |
| | 7.5 | Involving avidin-biotin binding |
| | 7.6 | Involving a modified enzyme (e.g., abzyme, recombinant, chemically altered, etc.) |
| | 7.7 | Assay in which a label present is an apoenzyme, prosthetic group, or enzyme cofactor |
| | 7.71 | Assay in which a label present is an enzyme inhibitor or functions to alter enzyme activity |
| | 7.72 | Assay in which a label present is an enzyme substrate or substrate analogue |
| | 7.8 | Involving nonmembrane bound receptor binding or protein binding other than antigen-antibody binding |
| | 7.9 | Assay in which an enzyme present is a label |
| | 8 | Involving luciferase |
| | 9 | Geomicrobiological testing (e.g., for petroleum, etc.) |
| | 10 | Involving uric acid |
| | 11 | Involving cholesterol |
| | 12 | Involving urea or urease |
| | 13 | Involving blood clotting factor (e.g., involving thrombin, thromboplastin, fibrinogen, etc.) |
| | 14 | Involving glucose or galactose |
| | 15 | Involving transferase |
| | 18 | Involving hydrolase |
| | 25 | Involving oxidoreductase |
| | 29 | Involving viable micro-organism |
| | 30 | Methods of sampling or inoculating or spreading a sample; methods of physically isolating an intact micro-organism |
| | 31 | Testing for sterility condition |
| | 32 | Testing for antimicrobial activity of a material |
| | 34 | Determining presence or kind of micro-organism; use of selective media |
| | 40.5 | Involving fixed or stabilized, nonliving microorganism, cell, or tissue (e.g., processes of staining, stabilizing, dehydrating, etc.; compositions used therefore, etc.) |
| | 41 | MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION |
| | 42 | Process involving micro-organisms of different genera in the same process, simultaneously |
| | 43 | Preparing compound having a 1-thia-4-aza-bicyclo (3.2.0) heptane ring system (e.g., penicillin, etc.) |
| | 44 | By desacylation of the substituent in 6-position |
| | 45 | By acylation of the substituent in 6-position |
| | 46 | In presence of phenyl acetic acid or phenyl acetamide or their derivatives |
| | 47 | Preparing compound having a 1-thia-5-aza-bicyclo (4.2.0) octane ring system (e.g., cephalosporin, etc.) |
| | 48 | Di-substituted in 7-position |
| | 49 | Cephalosporin C |
| | 50 | By acylation of the substituent in the 7-position |
| | 51 | By desacylation of the substituent in the 7-position |
| | 52 | Preparing compound containing a cyclopentanohydrophenanthrene nucleus; nor-, homo-, or D-ring lactone derivatives thereof |
| | 53 | Containing heterocyclic ring |
| | 54 | Acting on D-ring |
| | 58 | Hydroxylating |
| | 61 | Dehydrogenating; dehydroxylating |
| | 63 | Preparing compound containing a prostaglandin nucleus |
| | 64 | Preparing compound other than saccharide containing a tetracycline nucleus (e.g., naphacene, etc.) |
| | 65 | Preparing compound other than saccharide containing a gibberellin nucleus (i.e., gibbane) |
| | 66 | Preparing compound other than saccharide containing alloxazine or isoalloxazine nucleus |
| | 67 | Preparing compound containing a carotene nucleus (i.e., carotene) |
| | 68.1 | Enzymatic production of a protein or polypeptide (e.g., enzymatic hydrolysis, etc.) |
| | 69.1 | Recombinant DNA technique included in method of making a protein or polypeptide |
| | 69.2 | Enzyme inhibitors or activators |
| | 69.3 | Antigens |
| | 69.4 | Hormones and fragments thereof |
| | 69.5 | Lymphokines or monokines |
| | 69.6 | Blood proteins |
| | 69.7 | Fusion proteins or polypeptides |
| | 69.8 | Signal sequence (e.g., beta-galactosidase, etc.) |
| | 70.1 | Using tissue cell culture to make a protein or polypeptide |
| | 71.1 | Using a micro-organism to make a protein or polypeptide |
| | 72 | Preparing compound containing saccharide radical |
| | 73 | Preparing S-glycoside (e.g., lincomycin, etc.) |
| | 74 | Preparing O-glycoside (e.g., glucosides, etc.) |
| | 76 | The hetero ring has eight or more ring members and only oxygen as ring hetero atoms (e.g., erythromycin, spiramycin, nystatin, etc.) |
| | 77 | Oxygen atom of the saccharide radical is directly linked through only acyclic carbon atoms to a nonsaccharide heterocyclic ring (e.g., bleomycin, phleomycin, etc.) |
| | 78 | Oxygen atom of the saccharide radical is directly bonded to a condensed ring system having three or more carboxyclic rings (e.g., dauomycin, adriamycin, etc.) |
| | 79 | Oxygen atom of the saccharide radical is bonded to a cyclohexyl radical (e.g., kasugamycin, etc.) |
| | 80 | Cyclohexyl radical is substituted by two or more nitrogen atoms (e.g., destomycin, neamin, etc.) |
| | 84 | Preparing nitrogen-containing saccharide |
| | 85 | N-glycoside |
| | 86 | Cobalamin (i.e., vitamin B12, LLD factor) |
| | 87 | Nucleoside |
| | 88 |  Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine nucleosides, etc.) |
| | 89 | Nucleotide |
| | 90 | Dinucleotide (e.g., NAD, etc.) |
| | 91.1 | Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) |
| | 91.2 |  Acellular exponential or geometric amplification (e.g., PCR, etc.) |
| | 91.3 | Polynucleotide contains only ribonucleotide monomers |
| | 91.4 | Modification or preparation of a recombinant DNA vector |
| | 91.41 |  By insertion or addition of one or more nucleotides |
| | 91.42 | Involving deletion of a nucleotide or nucleotides from a vector |
| | 91.5 | Acellular preparation of polynucleotide |
| | 92 | Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine based mononucleotides, etc.) |
| | 93 | Mashing or wort making |
| | 94 | Produced by the action of an isomerase (e.g., fructose by the action of xylose isomerase on glucose, etc.) |
| | 95 | Produced by the action of a beta-amylase (e.g., maltose by the action of beta-amylase on amylose, etc.) |
| | 96 | Produced by the action of an exo-1.4 alpha glucosidase (e.g., dextrose by the action of glucoamylase on starch, etc.) |
| | 97 | Produced by the action of a glycosyl transferase (e.g., alpha, beta, gamma-cyclodextrins by the action of glycosyl transferase on starch, etc.) |
| | 98 | Produced by the action of an alpha-1, 6-glucosidase (e.g., amylose debranched amylopectin by the action of pullulanase, etc.) |
| | 99 | Produced by the action of a carbohydrase (e.g., maltose by the action of alpha amylase on starch, etc.) |
| | 100 | Disaccharide |
| | 101 | Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds |
| | 105 | Monosaccharide |
| | 106 | Preparing alpha or beta amino acid or substituted amino acid or salts thereof |
| | 107 | Proline; hydroxyproline; histidine |
| | 108 | Tryptophan; tyrosine; phenylalanine; 3,4 dihydroxyphenylalanine |
| | 109 | Aspartic acid (asparaginic acid); asparagine |
| | 110 | Glutamic acid; glutamine |
| | 111 | Utilizing biotin or its derivatives |
| | 112 | Utilizing surfactant fatty acids or fatty acid esters (i.e., having seven or more atoms) |
| | 113 | Methionine; cysteine; cystine |
| | 114 | Citrulline; arginine; ornithine |
| | 115 | Lysine; diaminopimelic acid; threonine; valine |
| | 116 | Alanine; leucine; isoleucine; serine; homoserine |
| | 117 | Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms |
| | 118 | Containing two or more hetero rings |
| | 119 | Containing at least two hetero rings bridged or fused among themselves or bridged or fused with a common carbocyclic ring system, (e.g., rifamycin, etc.) |
| | 120 | Nitrogen or oxygen hetero atom and at least one other diverse hetero ring atom in the same ring |
| | 121 | Nitrogen as only ring hetero atom |
| | 123 | Oxygen as only ring hetero atom |
| | 127 | Preparing compound containing at least three carbocyclic rings |
| | 128 | Preparing nitrogen-containing organic compound |
| | 130 | Preparing sulfur-containing organic compound |
| | 131 | Preparing organic compound containing a metal or atom other than H, N, C, O, or halogen |
| | 132 | Preparing oxygen-containing organic compound |
| | 133 | Containing quinone nucleus (i.e., quinoid structure) |
| | 134 | Fat; fatty oil; ester-type wax; higher fatty acid (i.e., having at least seven carbon atoms in an unbroken chain bound to a carboxyl group); oxidized oil or fat |
| | 135 | Carboxylic acid ester |
| | 136 | Containing a carboxyl group |
| | 137 | Sugar acid having five or more carbon atoms (i.e., aldonic, keto-aldonic, or saccharic acid) |
| | 139 | Lactic acid |
| | 140 | Acetic acid |
| | 141 | Propionic or butyric acid |
| | 142 | Polycarboxylic acid |
| | 143 | Having keto group (e.g., alpha-ketoglutaric acid, etc.) |
| | 144 | Tricarboxylic acid (e.g., citric acid, etc.) |
| | 145 | Dicarboxylic acid having four or less carbon atoms (e.g., fumaric, maleic, etc.) |
| | 146 | Hydroxy carboxylic acid |
| | 147 | Containing carbonyl group |
| | 155 | Containing hydroxy group |
| | 166 | Preparing hydrocarbon |
| | 168 | Preparing element or inorganic compound except carbon dioxide |
| | 169 | Using actinomycetales |
| | 170 | Using bacteria |
| | 171 | Using fungi |
| | 440 | PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION |
| | 441 | Mutation employing a chemical mutagenic agent |
| | 442 | By replacement of standard nucleic acid base with base analog (e.g., 5-bromouracil, etc.) |
| | 443 | By use of intercalating agent (e.g., acridine orange, etc.) |
| | 444 | By use of alkylating agent (e.g., nitrosoguanidine, etc.) |
| | 445 | By use of oxidative deamination agent (e.g., nitrous acid, etc.) |
| | 446 | Mutation employing radiation or electricity |
| | 449 | Fusion of cells |
| | 450 | Employing electric current |
| | 451 | One of the fusing cells is a human antibody-producing cell |
| | 452 | One of the fusing cells is a mouse antibody-producing cell |
| | 453 | One of the fusing cells is a plant cell |
| | 454 | One of the fusing cells is a microorganism (e.g., prokaryote, fungus, etc.) |
| | 455 | Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell |
| | 456 | The polynucleotide is encapsidated within a virus or viral coat |
| | 458 | The polynucleotide is coated with or encapsulated within a lipid containing material (e.g., liposome, etc.) |
| | 459 | Involving particle-mediated transfection (i.e., biolistic transfection) |
| | 460 | Involving laser treatment of the cell before or during transfection |
| | 461 | Involving electroporation |
| | 462 | Involving site-specific recombination (e.g., Cre-lox, etc.) |
| | 463 | Involving general or homologous recombination (e.g., gene targeting, etc.) |
| | 464 | Involving gene duplication within the cell (e.g., amplification, co-amplification, etc.) |
| | 465 | Involving co-transfection |
| | 466 | The polynucleotide is a shuttle vector or a transiently replicating hybrid vector |
| | 467 | Introducing an oncogene to establish a cell line |
| | 468 | Introduction of a polynucleotide molecule into or rearrangement of a nucleic acid within a plant cell |
| | 469 | Introduction via Agrobacterium |
| | 470 | Introduction via electroporation, particle, fiber or microprojectile mediated insertion, or injection |
| | 471 | Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within a microorganism (e.g., bacteria, protozoa, bacteriophage, etc.) |
| | 472 | The polynucleotide is encapsidated within a bacteriophage, bacteriophage coat, or transducing particle |
| | 473 | The polynucleotide contains a transposon |
| | 474 | The polynucleotide is a cosmid |
| | 475 | The polynucleotide is unencapsidated bacteriophage or viral nucleic acid |
| | 476 | The polynucleotide is a plasmid or episome |
| | 477 | Plasmid or episome contains DNA targeting homologous recombination to bacteriophage, viral, or chromosomal DNA within a microorganism |
| | 478 | Plasmid or episome contains at least part of a gene encoding a restriction endonuclease or modification enzyme |
| | 479 | Plasmid or episome confers the ability to utilize directly a compound which a wild type microorganism is unable to utilize |
| | 480 | Plasmid or episome contains at least part of a gene encoding a toxin or encoding for virulence or pathogenicity |
| | 481 | Plasmid or episome contains a gene which complements a nutritional deficiency mutation |
| | 482 | Plasmid or episome contains a gene which confers resistance to metal, silicon, selenium, or tellurium toxicity |
| | 483 | Yeast is a host for the plasmid or episome |
| | 484 | Mycelial fungus is a host for the plasmid or episome |
| | 485 | Microorganism of the genus Bacillus is a host for the plasmid or episome |
| | 486 | Microorganism of the genus Streptomyces is a host for the plasmid or episome |
| | 487 | Microorganism of the genus Brevibacterium or the genus Corynebacterium is a host for the plasmid or episome |
| | 488 | Microorganism of the genus Escherichia is a host for the plasmid or episome |
| | 489 | Plural nonidentical plasmids are introduced into a host microorganism or culture thereof (e.g., plasmid is part of a library, etc.) |
| | 490 | The polynucleotide is an unbranched linear fragment |
| | 173.1 | TREATMENT OF MICRO-ORGANISMS OR ENZYMES WITH ELECTRICAL OR WAVE ENERGY (E.G., MAGNETISM, SONIC WAVES, ETC.) |
| | 173.2 | Enzyme treated |
| | 173.3 | Modification of viruses (e.g., attenuation, etc.) |
| | 173.4 | Cell membrane or cell surface is target |
| | 173.5 | Membrane permeability increased |
| | 173.7 | Lytic effect produced (e.g., disruption of cell membrane for release of subcellular parts; e.g., nucleic acids, etc.) |
| | 173.8 | Metabolism of micro-organism enhanced (e.g., growth enhancement or increased production of microbial product) |
| | 173.9 | Concentration, separation, or purification of micro-organisms |
| | 174 | CARRIER-BOUND OR IMMOBILIZED ENZYME OR MICROBIAL CELL; CARRIER-BOUND OR IMMOBILIZED CELL; PREPARATION THEREOF |
| | 175 | Multi-enzyme system |
| | 176 | Enzyme or microbial cell is immobilized on or in an inorganic carrier |
| | 177 | Enzyme or microbial cell is immobilized on or in an organic carrier |
| | 183 | ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES |
| | 184 | Enzyme inactivation by chemical treatment |
| | 185 | Malt |
| | 186 | Pancreatin |
| | 187 | Preparing granular- or free-flowing enzyme composition |
| | 188 | Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate |
| | 188.5 | Catalytic antibody |
| | 189 | Oxidoreductase (1. ) (e.g., luciferase) |
| | 190 | Acting on CHOH group as donor (e.g., glucose oxidase, lactate dehydrogenase (1.1)) |
| | 191 | Acting on nitrogen-containing compound as donor (1.2, 1.5, 1.7) |
| | 192 | Acting on hydrogen peroxide as acceptor (1.11) |
| | 193 | Transferase other than ribonuclease (2.) |
| | 195 | Hydrolase (3. ) |
| | 196 | Acting on ester bond (3.1) |
| | 200 | Acting on glycosyl compound (3.2) |
| | 201 | Acting on alpha-1, 4-glucosidic bond, (e.g., hyaluronidase, invertase, amylase, etc. (some 3.2.1)) |
| | 202 | Alpha-amylase, microbial source |
| | 204 | Alpha-amylase, plant source (3.2.1.1) |
| | 205 | Glucoamylase (3.2.1.3) |
| | 206 | Acting on beta-1, 4 link between N-acetylmuramic acid and 2-acetylamino 2 deoxy-D-glucose (e.g., lysozyme, etc.) |
| | 207 | Acting on beta-galatose-glycoside bond (e.g., beta-galactosidase, etc.) |
| | 208 | Acting on alpha-galatose-glycoside bond (e.g., alpha-galactosidase, etc.) |
| | 209 | Acting on beta-1, 4-glucosidic bond (e.g., cellulase, etc. (3.2.1.4)) |
| | 210 | Acting on alpha-1, 6-glucosidic bond (e.g., isoamylase, pullulanase, etc.) |
| | 212 | Acting on peptide bond (e.g., thromboplastin, leucine amino-peptidase, etc., (3.4)) |
| | 213 | Trypsin; chymotrypsin |
| | 214 | Thrombin |
| | 215 | Urokinase |
| | 216 | Streptokinase |
| | 217 | Plasmin (i.e., fibrinolysin) |
| | 218 | Elastase |
| | 219 | Proteinase |
| | 227 | Acting on carbon to nitrogen bond other than peptide bond (3.5) |
| | 232 | Lyase (4. ) |
| | 233 | Isomerase (5. ) |
| | 235.1 | VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING |
| | 325 | ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE |
| | 326 | Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof |
| | 327 | Immunoglobulin or antibody is anti-idiotypic |
| | 328 | Immunoglobulin or antibody is chimeric, mutated, or a recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobuin fusion protein, etc.) |
| | 329 | Immunoglobulin or antibody binds an oligosaccharide structure other than nucleic acid |
| | 330 | Immunoglobulin or antibody binds an expression product of a cancer related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
| | 331 | Immunoglobulin or antibody binds a specifically identified amino acid sequence |
| | 332 | Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) |
| | 333 | Binds a nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA, hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.) |
| | 334 | Binds a receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.) |
| | 337 | Binds a plasma protein, serum protein, or fibrin (e.g., clotting factor fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
| | 338 | Binds an enzyme |
| | 339 | Binds a virus or component or product thereof (e.g., virus associated antigen, etc.) |
| | 340 | Binds a bacterium or similar microorganism or component or product thereof (e.g., Streptococcus, Legionella, Mycoplasma, bacterium associated antigen, exotoxin, etc.) |
| | 341 | Binds a fungus or plant cell or component or product thereof (e.g., fungus associated antigen, etc.) |
| | 342 | Binds a parasitic protozoan or metazoan cell or component or product thereof; (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell surface antigen, etc.) |
| | 344 | Binds a cancer cell or component or product thereof (e.g., cell surface antigen, etc.) |
| | 345 | Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.) |
| | 346 | Fused or hybrid cell, per se |
| | 347 | Two or more cell types, per se, in co-culture |
| | 348 | Insect cell, per se |
| | 349 | Avian cell, per se |
| | 350 | Canine cell, per se |
| | 351 | Feline cell, per se |
| | 352 | Rodent cell, per se |
| | 353 | Rat (i.e., Rattus) |
| | 354 | Mouse (i.e., Mus) |
| | 355 | Blood or lymphatic origin or derivative |
| | 356 | L cell or derivative (e.g., Ltk(-), etc.) |
| | 357 | Fibroblast, fibroblast-like cell or derivative (e.g., NIH 3T3, etc.) |
| | 358 | Chinese hamster ovary (i.e., CHO) |
| | 363 | Primate cell, per se |
| | 364 | Monkey kidney |
| | 366 | Human |
| | 373 | Method of co-culturing cells |
| | 374 | Method of storing cells in a viable state |
| | 375 | Method of regulating cell metabolism or physiology |
| | 376 | Method of synchronizing cell division |
| | 377 | Method of altering the differentiation state of the cell |
| | 378 | Method of detaching cells, digesting tissue or establishing a primary culture |
| | 379 | Using mechanical means (e.g., trituration, etc.) |
| | 380 | Releasing bound or adhered cell using protease |
| | 381 | Digesting tissue with protease |
| | 382 | Method of culturing encapsulated cells |
| | 383 | Method of culturing cells in suspension |
| | 384 | Culture medium contains a growth factor or growth regulator |
| | 385 | Medium contains a colony stimulating factor |
| | 386 | Medium contains an interleukin |
| | 387 | Medium contains a polypeptide hormone |
| | 388 | Culture medium contains an albumin |
| | 389 | Culture medium contains a transferrin |
| | 390 | Culture medium contains an incompletely defined plant or microbial extract excluding animal extract |
| | 391 | Culture medium contains an animal extract |
| | 393 | Using airlift or laminar flow aeration or foam culture |
| | 394 | Wherein culture vessel is rotated or oscillated or culture is agitated |
| | 395 | Solid support and method of culturing cells on said solid support |
| | 396 | Support is a resin |
| | 397 | Support is a gel surface |
| | 398 | Support is a fiber |
| | 401 | Support is a membrane |
| | 402 | Support is a coated or treated surface |
| | 403 | Support is a suspendable particle |
| | 404 | Culture medium, per se |
| | 410 | PLANT CELL OR CELL LINE, PER SE (E.G., TRANSGENIC, MUTANT, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING, OR PRESERVING PLANT CELL OR CELL LINE; PROCESS OF ISOLATING OR SEPARATING A PLANT CELL OR CELL LINE; PROCESS OF REGENERATING PLANT CELLS INTO TISSUE, PLANT PART, OR PLANT, PER SE, WHERE NO GENOTYPIC CHANGE OCCURS; MEDIUM THEREFORE |
| | 411 | Tomato cell or cell line, per se |
| | 412 | Corn cell or cell line, per se |
| | 414 | Tobacco cell or cell line, per se |
| | 415 | Soybean cell or cell line, per se |
| | 416 | Sunflower cell or cell line, per se |
| | 417 | Potato cell or cell line, per se |
| | 418 | Plant cell or cell line, per se, is pest or herbicide resistant or pest lethal |
| | 419 | Plant cell or cell line, per se, contains exogenous or foreign nucleic acid |
| | 420 | Culture, maintenance, or preservation techniques, per se |
| | 421 | Involving protoplast |
| | 422 | Involving conifer cell or tissue (e.g., pine, spruce, fir, cedar, etc.) |
| | 423 | Involving tomato cell or tissue |
| | 424 | Involving corn cell or tissue |
| | 425 | Involving tobacco cell or tissue |
| | 426 | Involving soybean cell or tissue |
| | 427 | Involving cotton cell or tissue |
| | 428 | Involving sunflower cell or tissue |
| | 429 | Involving potato cell or tissue |
| | 430 | Involving regeneration or propagation into a plant or plant part |
| | 431 | Medium, per se, for culture, maintenance, regeneration, etc. |
| | 242 | SPORE FORMING OR ISOLATING PROCESS |
| | 243 | MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR |
| | 244 | Chemical stimulation of growth or activity by addition of chemical compound which is not an essential growth factor; stimulation of growth by removal of a chemical compound |
| | 245 | Adaptation or attenuation of cells |
| | 246 | Foam culture |
| | 247 | Utilizing media containing lower alkanol (i.e., having one to six carbon atoms) |
| | 248 | Utilizing media containing hydrocarbon |
| | 251 | Utilizing media containing waste sulphite liquor |
| | 252 | Utilizing media containing cellulose or hydrolysates thereof |
| | 252.1 | Bacteria or actinomycetales; media therefor |
| | 252.2 | Rhizobium or agrobacterium |
| | 252.3 | Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.) |
| | 252.31 | Bacillus (e.g., B. subtilis, B. thuringiensis, etc.) |
| | 252.32 | Brevibacterium or corynebacterium |
| | 252.33 | Escherichia (e.g., E. coli, etc.) |
| | 252.34 | Pseudomonas |
| | 252.35 | Streptomyces |
| | 252.4 | Mixed culture |
| | 252.5 | Bacillus (e.g., B. subtilis, B. thuringiensis, etc.) |
| | 252.6 | Actinoplanes |
| | 252.7 | Clostridium |
| | 252.8 | Escherichia (e.g., E. coli, etc.) or salmonella |
| | 252.9 | Lactobacillus, pediococcus, or leuconostoc |
| | 253.1 | Mycobacterium |
| | 253.2 | Nocardia |
| | 253.3 | Pseudomonas |
| | 253.4 | Streptococcus |
| | 253.5 | Streptomyces |
| | 253.6 | Culture media, per se |
| | 254.1 | Fungi |
| | 254.11 | Transformants |
| | 254.2 | Yeast; media therefor |
| | 254.3 | Aspergillus |
| | 254.4 | Neurospora |
| | 254.5 | Penicillium |
| | 254.6 | Trichoderma |
| | 254.7 | Fusarium |
| | 254.8 | Mucor |
| | 254.9 | Rhizopus |
| | 255.1 | Yeast |
| | 255.2 | Saccharomyces |
| | 255.3 | Cryptococcus |
| | 255.4 | Candida or torulopsis |
| | 255.5 | Pichia |
| | 255.6 | Hansenula |
| | 255.7 | Culture media, per se, or technique |
| | 256.1 | Aspergillus |
| | 256.2 | Mucor |
| | 256.3 | Penicillium |
| | 256.4 | Cephalosporium or acremonium |
| | 256.5 | Fusarium |
| | 256.6 | Rhizopus |
| | 256.7 | Trichoderma |
| | 256.8 | Culture media, per se, or technique |
| | 257.1 | Algae, media therefor |
| | 258.1 | Protozoa, media therefor |
| | 259 | Lysis of micro-organism |
| | 260 | Preserving or maintaining micro-organism |
| | 261 | Separation of micro-organism from culture media |
| | 320.1 | VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) |
| | 262 | PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES |
| | 262.5 | Destruction of hazardous or toxic waste |
| | 263 | Textile treating |
| | 264 | Cleaning using a micro-organism or enzyme |
| | 265 | Depilating hides, bating, or hide treating using enzyme or micro-organism |
| | 266 | Treating gas, emulsion, or foam |
| | 267 | Treating animal or plant material or micro-organism |
| | 268 | Treating organ or animal secretion |
| | 269 | Treating blood fraction |
| | 270 | Removing nucleic acid from intact or disrupted cell |
| | 271 | Glyceridic oil, fat, ester-type wax, or higher fatty acid recovered or purified |
| | 272 | Proteinaceous material recovered or purified |
| | 274 | Carbohydrate material recovered or purified |
| | 280 | Resolution of optical isomers or purification of organic compounds or composition containing same |
| | 281 | Petroleum oil or shale oil treating |
| | 283.1 | APPARATUS |
| | 284.1 | Differentiated tissue (e.g., organ) perfusion or preservation apparatus |
| | 285.1 | Mutation or genetic engineering apparatus |
| | 285.2 | With means for applying an electric current or charge (e.g., electrofusion, electroporation, etc.) |
| | 285.3 | Including projectile means |
| | 286.1 | Including condition or time responsive control means |
| | 286.2 | Including position control |
| | 286.5 | Including liquid flow, level, or volume control |
| | 286.6 | Including gas flow or pressure control |
| | 286.7 | Including mixing or agitation control |
| | 287.1 | Including measuring or testing |
| | 287.2 | Measuring or testing for antibody or nucleic acid, or measuring or testing using antibody or nucleic acid |
| | 287.3 | With sample or reagent mechanical transport means |
| | 287.4 | Sterility testing means |
| | 287.5 | Means for measuring gas pressure or gas volume of gas evolved from or consumed in an enzymatic or microbial reaction |
| | 287.6 | Including frangible means for introducing a sample or reagent |
| | 287.7 | Including bibulous or absorbent layer |
| | 287.9 | Including a coated reagent or sample layer |
| | 288.1 | Including a bottle, tube, flask, or jar |
| | 288.3 | Including a dish, plate, slide, or tray |
| | 288.6 | Including column separation means |
| | 288.7 | Including optical measuring or testing means |
| | 289.1 | Bioreactor |
| | 290.1 | Composting apparatus |
| | 290.2 | Including agitation means |
| | 290.4 | Including solid or liquid transport means into or out of a compostor |
| | 291.1 | Malting or mashing apparatus |
| | 291.2 | Movable floor to facilitate maintenance (e.g., cleaning) |
| | 291.3 | Vertically spaced stages, levels, or floors |
| | 291.5 | With agitator or mash turner |
| | 292.1 | Including means to transmit light into a bioreactor to facilitate photo- bioreaction (e.g., photosynthesis) |
| | 293.1 | Tubular or plug flow bioreactor |
| | 294.1 | Vessels or trays in series |
| | 295.1 | Including a draft tube for agitation |
| | 296.1 | Bubble bioreactor |
| | 297.1 | Including semipermeable membrane or filter |
| | 297.2 | Including perfusion means |
| | 297.3 | Including a spinning semipermeable membrane or filter |
| | 297.4 | Including hollow fiber or capillary |
| | 297.5 | In combination with a dish, plate, or tray |
| | 298.1 | Cylindrical reaction tank or vessel horizontally disposed with respect to its central axis |
| | 299.1 | Including solid extended fluid contact reaction surface |
| | 300.1 | Including off-gas trapping means |
| | 301.1 | Including foam breaking means |
| | 302.1 | Including magnetically coupled agitation means |
| | 303.1 | Incubator |
| | 303.2 | Specifically adapted for an anaerobic microorganism or enzyme (e.g., anaerobe jars) |
| | 303.3 | Including an agitator |
| | 304.1 | Bottle, tube, jar, or flask |
| | 305.1 | Dish, plate, or tray |
| | 306.1 | Involving lysis of a microorganism by means other than comminution |
| | 307.1 | Microorganism preservation, storage, or transport apparatus |
| | 308.1 | Means for separation or recovery of a microorganism from culture media |
| | 309.1 | Inoculator, streaker, or sampler |
| | 317.1 | MISCELLANEOUS (E.G., SUBCELLULAR PARTS OF MICRO-ORGANISMS, ETC.) |
| CROSS-REFERENCE ART COLLECTIONS | ||
| | 800 | ELIMINATION OR REDUCTION OF CONTAMINATION BY UNDERSIRED FERMENTS (E.G., ASEPTIC CULTIVATION) |
| | 801 | ANEROBIC CULTIVATION |
| | 802 | LOGARITHMIC GROWTH PHASE |
| | 803 | PHYSICAL RECOVERY METHODS (E.G., CHROMATOGRAPHY, GRINDING) |
| | 804 | SINGLE CELL PROTEIN |
| | 805 | TEST PAPERS |
| | 806 | FERTILITY TESTS |
| | 807 | GAS DETECTION APPARATUS |
| | 808 | OPTICAL SENSING APPARATUS |
| | 809 | INCUBATORS OR RACKS OR HOLDERS FOR CULTURE PLATES OR CONTAINERS |
| | 810 | PACKAGED DEVICE OR KIT |
| | 811 | INTERFERON |
| | 812 | FOAM CONTROL |
| | 813 | CONTINUOUS FERMENTATION |
| | 814 | ENZYME SEPARATION OR PURIFICATION |
| | 817 | ENZYME OR MICROBE ELECTRODE |
| | 818 | AERATION OR OXYGEN TRANSFER TECHNIQUE |
| | 819 | FERMENTATION VESSELS IN SERIES |
| | 820 | SUBCELLULAR PARTS OF MICRO-ORGANISMS |
| | 821 | MICRO-ORGANISMS USED IN THE DESTRUCTION OF HAZARDOUS OR TOXIC WASTE |
| MICRO-ORGANISM CROSS-REFERENCE ART COLLECTIONS |
| | 822 | Using bacteria or actinomycetales |
| | 823 | Acetobacter |
| | 824 | Achromobacter |
| | 825 | Actinomadura |
| | 826 | Actinomyces |
| | 827 | Actinoplanes |
| | 828 | Aerobacter |
| | 829 | Alcaligenes |
| | 830 | Arthrobacter |
| | 831 | Azotobacter |
| | 832 | Bacillus |
| | 833 | Bacillus brevis |
| | 834 | Bacillus cereus |
| | 835 | Bacillus circulans |
| | 836 | Bacillus licheniformis |
| | 837 | Bacillus megaterium |
| | 838 | Bacillus polymyxa |
| | 839 | Bacillus subtilis |
| | 840 | Brevibacterium |
| | 841 | Chainia |
| | 842 | Clostridium |
| | 843 | Corynebacterium |
| | 847 | Erwinia |
| | 848 | Escherichia |
| | 850 | Flavobacterium |
| | 851 | Haemophilus |
| | 852 | Klebsiella |
| | 853 | Lactobacillus |
| | 854 | Lactobacillus acidophilus |
| | 855 | Lactobacillus brevis |
| | 856 | Lactobacillus casei |
| | 857 | Lactobacillus plantarum |
| | 858 | Methylomonas |
| | 859 | Micrococcus |
| | 863 | Mycobacterium |
| | 867 | Micromonospora |
| | 870 | Mycoplasma |
| | 871 | Neisseria |
| | 872 | Nocardia |
| | 873 | Proteus |
| | 874 | Pseudomonas |
| | 878 | Rhizobium |
| | 879 | Salmonella |
| | 880 | Serratia |
| | 882 | Staphylococcus |
| | 885 | Streptococcus |
| | 886 | Streptomyces |
| | 887 | Streptomyces albus |
| | 888 | Streptomyces antibioticus |
| | 889 | Streptomyces aureofaciens |
| | 890 | Streptomyces aureus |
| | 891 | Streptomyces bikiniensia |
| | 892 | Streptomyces candidus |
| | 893 | Streptomyces chartreusis |
| | 894 | Streptomyces diastatochromogenes |
| | 895 | Streptomyces filipinensis |
| | 896 | Streptomyces fradiae |
| | 897 | Streptomyces griseus |
| | 898 | Streptomyces hygroscopicus |
| | 899 | Streptomyces lavendulae |
| | 900 | Streptomyces lincolnensis |
| | 901 | Streptomyces noursei |
| | 902 | Streptomyces olivaceus |
| | 903 | Streptomyces platensis |
| | 904 | Streptomyces rimosus |
| | 905 | Streptomyces sparogenes |
| | 906 | Streptomyces venezuelae |
| | 907 | Streptosporangium |
| | 908 | Streptovirticillium |
| | 909 | Vibrio |
| | 910 | Xanthomonas |
| | 911 | Using fungi |
| | 912 | Absidia |
| | 913 | Aspergillus |
| | 914 | Aspergillus awamori |
| | 915 | Aspergillus flavus |
| | 916 | Aspergillus fumigatus |
| | 917 | Aspergillus niger |
| | 918 | Aspergillus oryzae |
| | 919 | Aspergillus ustus |
| | 920 | Aspergillus wenti |
| | 921 | Candida |
| | 925 | Cephalosporium |
| | 929 | Fusarium |
| | 930 | Hansenula |
| | 931 | Mucor |
| | 932 | Paecilomyces |
| | 933 | Penicillium |
| | 938 | Pichia |
| | 939 | Rhizopus |
| | 940 | Saccharomyces |
| | 944 | Torulopsis |
| | 945 | Trichoderma |
| | 946 | Using algae |
| | 947 | Using protozoa |
| | 948 | Using viruses or cell lines |
| CROSS-REFERENCE ART COLLECTIONS | ||
| RELATED TO SUBCLASSES |
| 7.1 THROUGH 7.95 |
| | 960 | IMMUNOHISTOCHEMICAL ASSAY |
| | 961 | INCLUDING A STEP OF FORMING, RELEASING, OR EXPOSING THE ANTIGEN OR FORMING THE HAPTEN-IMMUNOGENIC CARRIER COMPLEX OR THE ANTIGEN, PER SE |
| | 962 | PREVENTION OR REMOVAL OF INTERFERING MATERIALS OR REACTANTS OR OTHER TREATMENT TO ENHANCE RESULTS (E.G., DETERMINING OR PREVENTING NONSPECIFIC BINDING, ETC.) |
| | 963 | METHODS OF STOPPING AN ENZYME REACTION OR STABILIZING THE TEST MATERIALS |
| | 964 | INCLUDING ENZYME-LIGAND CONJUGATE PRODUCTION (E.G., REDUCING RATE OF NONPRODUCTIVE LINKAGE, ETC.) |
| | 965 | INVOLVING IDIOTYPE OR ANTI-IDIOTYPE ANTIBODY |
| | 966 | INVOLVING AN ENZYME SYSTEM WITH HIGH TURNOVER RATE OR COMPLEMENT MAGNIFIED ASSAY (E.G., MULTI-ENZYME SYSTEMS, ETC.) |
| | 967 | STANDARDS, CONTROLS, MATERIALS (E.G., VALIDATION STUDIES, BUFFER SYSTEMS, ETC.) |
| | 968 | HIGH ENERGY SUBSTRATES (E.G., FLUORESCENT, CHEMILUMINESCENT, RADIOACTIVE, ETC.) |
| | 969 | MULTIPLE LAYERING OF REACTANTS |
| | 970 | TEST STRIP OR TEST SLIDE |
| | 971 | CAPTURE OF COMPLEX AFTER ANTIGEN-ANTIBODY REACTION |
| | 972 | MODIFIED ANTIBODY (E.G., HYBRID, BIFUNCTIONAL, ETC.) |
| | 973 | SIMULTANEOUS DETERMINATION OF MORE THAN ONE ANALYTE |
| | 974 | AIDS RELATED TEST |
| | 975 | KIT |
| FOREIGN ART COLLECTIONS | ||
| FOR000 | CLASS-RELATED FOREIGN DOCUMENTS |
| Any foreign patents or non-patent literature from subclasses that have been reclassified have been transferred directly to FOR Collections listed below. These Collections contain ONLY foreign patents or non-patent literature. The parenthetical references in the Collection titles refer to the abolished subclasses from which these Collections were derived. | ||
| FOR100 | ANIMAL OR PLANT CELL (E.G., CELL LINES, ETC.); COMPOSITIONS THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING ANIMAL OR PLANT CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL OR PLANT CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING ANIMAL OR PLANT CELL; CULTURE MEDIA THEREFORE (435/240.1) |
| FOR101 | Animal cells, per se, culture techniques and media (435/240.2) |
| FOR102 | Techniques of establishing a primary culture (435/240.21) |
| FOR103 | Culture of encapsulated cells (435/240.22) |
| FOR104 | Culture of cells on solid support (e.g., anchorage dependent cells) (435/240.23) |
| FOR105 | Support is suspendable particle (435.240.24) |
| FOR106 | Culture of cells on membrane (435/240.241) |
| FOR108 | Solid support treated or coated to enhance attachment or growth (435/240.243) |
| FOR109 | Culture in suspension (435/240.25) |
| FOR110 | Fused or hybrid cells (435/240.26) |
| FOR112 | Culture medium, per se (435/240.3) |
| FOR114 | Plant cells, per se, culture techniques and media (435/240.4) |
| FOR123 | MUTATION OR GENETIC ENGINEERING (435/172.1) |
| FOR126 | OBTAINING THE DESIRED GENE; DNA, RNA PER SE AND THE MODIFICATION THEREOF OTHER THAN VECTOR MODIFICATION (935/1) |
| FOR127 | DNA-RNA hybrid (935/2) |
| FOR128 | RNA (935/3) |
| FOR131 | DNA, e.g., regulatory sequences, etc. (935/6) |
| FOR132 | Homopolymeric, e.g., poly d(A) sequence, etc. (935/7) |
| FOR133 | 12-75 nucleotides in length, e.g., primers, etc. (935/8) |
| FOR134 | Structural gene sequence (935/9) |
| FOR141 | Methods of producing DNA or RNA other than by expression vectors, e.g., culture of cells high in DNA, etc. (935/16) |
| FOR144 | Isolation or purification of DNA or RNA (935/19) |
| FOR147 | VECTORS AND METHODS OF MODIFYING VECTORS (935/22) |
| FOR158 | METHODS OF ENHANCING OR DIMINISHING EXPRESSION (935/33) |
| FOR159 | Eukaryotic cell (935/34) |
| FOR163 | Prokaryotic cell (935/38) |
| FOR164 | Transcription (935/39) |
| FOR167 | Gene dosage modification, e.g., copy number amplification, etc. (935/42) |
| FOR169 | Translation (935/44) |
| FOR172 | Fused protein or peptide (435/47) |
| FOR174 | Post translational modification (935/49) |
| FOR177 | METHODS OF INTRODUCING GENE INTO HOST CELL, E.G., TRANSFORMATION OR TRANSFECTION, ETC. (935/52) |
| FOR178 | Microinjection (935/53) |
| FOR179 | Microencapsulation, e.g., liposome vesicle, etc. (935/54) |
| FOR180 | Using vector, e.g., plasmid, etc. (935/55) |
| FOR184 | METHOD OF USE OF GENETICALLY ENGINEERED CELLS, E.G., OIL SPILL CLEANUP, ETC. (935/59) |
| FOR185 | To produce an identified chemical product, e.g., amino acid, etc. (935/60) |
| FOR187 | Control of genetic diseases or defects by use of added gene, e.g., gene therapy (935/62) |
| FOR188 | Use in animal husbandry (935/63) |
| FOR189 | Use in agriculture (935/64) |
| FOR190 | Vaccine production (935/65) |
| FOR191 | CELLS CONTAINING A VECTOR AND/OR EXOGENOUS GENE, PER SE; PROPAGATION THEREOF; OTHER MEMBRANE ENCAPSULATED DNA, E.G., PROTOPLASTS, ETC. (935/66) |
| FOR192 | Plant cells (935/67) |
| FOR193 | Fungal cells (935/68) |
| FOR195 | Animal cell (935/70) |
| FOR197 | Bacteria (935/72) |
| FOR201 | ASSAY RELATED TO GENETIC ENGINEERING (935/76) |
| FOR202 | Methods of analysis of nucleic acids (935/77) |
| FOR204 | Methods of selection of recombinant gene containing vector; materials therefore, e.g., replica plating, etc. (935/79) |
| FOR210 | GENETIC ENGINEERING APPARATUS (935/85) |
| FOR211 | Analytical, e.g., for autoradiography, etc. (935/86) |
| FOR213 | Synthesis, e.g., peptide or gene synthesizers, etc. (935/88) |
| FOR214 | HYBRID OR FUSED CELL TECHNOLOGY, METHODS OF IMMORTALIZING CELLS, E.G., HYBRIDOMA, ETC. (935/89) |
| FOR215 | Method of selection of the desired cell (935/90) |
| FOR216 | Of plant cells, e.g., protoplasts, etc. (935/91) |
| FOR217 | Using positive selection technique (935/92) |
| FOR218 | Method of production of hybrid or fused cells, e.g., chromosome or genome transfer techniques, etc. (935/93) |
| FOR220 | Fused or hybrid cell, per se (935/95) |
| FOR221 | Interspecies fusion (935/96) |
| FOR222 | Fungi, e.g., yeasts, etc. (935/97) |
| FOR223 | Plant cells (935/98) |
| FOR224 | Human cell 935/99) |
| FOR227 | Animal cell (935/102) |
| FOR231 | Method of use of the fused or hybrid cell or the product thereof (935/106) |
| FOR236 | MISCELLANEOUS (935/111) |
| MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP (435/4) |
| DIGESTS | ||